Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (1763)	8/10/2003 11:18:51 PM
From: Mike	Read Replies (1) \| Respond to of 3044

The badda bing dude is the MDCO's current stock price. At the time I was discussing it was between $12.50-$14.50. Now the MDCO's stock is now at $24. If that aint some bing I don't know what is. The stock has been as high as $28-BADDA BINGO. Just wait and watch. MDCO sales are 100% Angiomax. They don't have any other FDA approved product. How much clearer do they have to be to determine that? In addition, look at what has happened to MLNM. This stock will be in the single digits soon. They have all the "promise" in the world. But it's not the promise it's the bing boy, it's the cash. Can you make money? MDCO is going to breakeven the middle of this quarter. So whether they sell $75MM or $100MM they will blow away MLNM on the badda bing side which is cash. Both EPS and stock price. Later bing boy, Mike

To: Harold Engstrom who wrote (1763)	8/10/2003 11:26:56 PM
From: Mike	Read Replies (1) \| Respond to of 3044

Here is my previous post in Feb on this board. You be the judge if I was rude. To:microcapfun who wrote (1388) From: Mike Thursday, Feb 20, 2003 9:38 AM Respond to of 1764 Hello MLNM investors. I would like to ask for your expertise. I have been looking over MDCO and Angiomax product. Would love to have a discussion relative to this drug on the MDCO board. There has been heated discussions between MDCO investors and MLNM investors. I wish the MLNM investors well but many things happening to put pressure on MLNM. So I am in no way short MLNM. The Eli Lilly announcement yesterday on pricing decreases can't be seen as beneficial to the Integrelin profits. But this aside, I would like to have a discussion on Angiomax as a replacement to heparin. Not a replacement to any 2b/3a's. Sorry for the OT but if any astute people want to come over you would be welcome. Even if your short MDCO. Best of luck MLNM longs, Mike